Brazilian homegrown medtech given cause to celebrate
This article was originally published in Clinica
A new healthcare product innovation programme, greater support for the adoption of international standards and new earmarked funds totalling R$7 billion (US$3.5 billion) are among a flurry of medtech development initiatives that have been unveiled in Brazil in support of homegrown developers and manufacturers.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.